Global Regulators publish Good Machine Learning Practices (GMLP)

by | Nov 1, 2021 | AI, Analytics, Compliance, Consulting Group, Data, FDA, Guidance, ISO, Medical Devices, MedTech, QMS, Quality, Quality Systems, Regulatory, Requirements, Robotics, SaMD, Standardization, Standards


‌ 

It is no secret that AI/ML medical devices are under a special spotlight by international regulators this year. With more and more AI/ML SaMD’s being engineered, regulatory authorities like the FDA have been pushing for a more robust regulatory strategy. Last week, the FDA, Health Canada and the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) jointly published “10 Guiding Principles” for Good Machine Learning Practices (GMLP)[1]. These principles will lay the foundation for the newest branch of GxP’s aimed at developing safe and effective AI/ML medical devices.

Many of the foundational principles rely on good software engineering, such as data quality assurance, cybersecurity practices, data authenticity/integrity, and risk management. Additionally, the principles outline that the model’s intended integration into clinical workflow, and the benefits/risks should be leveraged throughout the total product life cycle. The following are additional principles outlined in the informal guidance:

  • Clinical study participants and data sets are representative of the intended patient population
  • Training data sets are independent of test sets
  • Selected reference datasets are based upon best available methods
  • Model design is tailored to the available data and reflects the intended use of the device
  • Focus is placed on the performance of the Human-AI team
  • Testing demonstrates device performance during clinically relevant conditions
  • Users are provided clear and essential information
  • Deployed models are monitored for performance, similar to post-market surveillance1

If you need assistance developing a medical device integrated with AI/ML, EMMA International’s team of experts can help with everything from a regulatory strategy, to developing software specification documentation, post-market vigilance, and beyond. Give us a call at 248-987-4497 or email info@emmainternational.com to find out more!


[1] FDA (2021) Good Machine Learning Practice for Medical Device Development: Guiding Principles retrieved on 10/31/2021 from: https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles

Madison Wheeler

Madison Wheeler

Director of Technical Operations - Ms. Wheeler serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Ms. Wheeler also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Ms. Wheeler holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This